AI study of breast cancer that has spread
Part of Cancer, Skin clinical trials.
This study uses artificial intelligence to analyze tissue samples from breast cancer that has spread to distant organs, like the liver or lungs. The goal is to develop a tool that predicts how breast cancer might spread, helping doctors personalize treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman diagnosed with breast cancer.
- Your breast cancer must have spread to your liver, bone, lung, or brain (distant metastasis).
- A tissue sample from the metastatic tumor must be stored at our hospital (Second Affiliated Hospital, Zhejiang University).
- You cannot have another type of cancer that has spread.
- Your complete medical records must be available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This trial uses MRI scans to predict if breast cancer has spread to additional lymph nodes beyond the first one that was biopsied. It may help women who have already had a positive sentinel lymph node biopsy and then had more lymph nodes removed.
This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.
Hear when a new Breast trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.